Key result
PKA inhibition reverses cAMP-mediated platelet suppression, while PKG inhibition potentiates it.
Why the study?
The effect of cAMP-dependent protein kinase (PKA) on P-selectin expression in human platelets had not been evaluated.
How do protein kinase A (PKA) and protein kinase G (PKG) regulate P-selectin expression in thrombin-stimulated human platelets?
How do protein kinase A (PKA) and protein kinase G (PKG) regulate P-selectin expression in thrombin-stimulated human platelets?
cAMP-induced inhibition of P-selectin expression in human platelets is primarily mediated by PKA, whereas PKG appears to promote P-selectin expression when cAMP levels are elevated.
Answers are grounded in this paper and cite their sources.
PKA primarily mediates cAMP suppression of platelet P-selectin while PKG may enhance it; leaves open in vivo relevance for thrombosis.
P-selectin is rapidly translocated from platelet alpha-granules following activation. Intracellular cyclic AMP (cAMP) is a potent inhibitory pathway that results in global downregulation of platelet activation. While cAMP-dependent protein kinase (PKA) has long been considered as the main mediator of cAMP-dependent effects, no study has yet evaluated its effect on P-selectin expression in human platelets. Pretreatment of thrombin-stimulated platelets with forskolin resulted in a concentration- dependent inhibition of P-selectin expression that correlated with adenylyl cyclase activity. Inhibition of PKA with H-89 reversed cAMP-induced inhibition of P-selectin while cGMP-dependent protein kinase (PKG) inhibition with KT5823 significantly potentiated cAMP-dependent inhibition of P-selectin. Similar results were also observed in a platelet/neutrophil binding assay. In conclusion, cAMP-induced inhibition of P-selectin expression is, in large part, mediated through activation of PKA. PKG appears to be solicited for P-selectin expression when cAMP levels are elevated which suggest a cAMP/PKG-dependent pathway of platelet activation.
No takes yet. Share an insight, caveat, or question.
Libersan et al. (2003) studied Thrombin-stimulated human platelets. Forskolin, H-89, and KT5823 was evaluated on P-selectin expression. Inhibition of PKA reversed cAMP-induced inhibition of P-selectin expression in thrombin-stimulated human platelets, while PKG inhibition potentiated it.
Synapse has enriched 10 related papers. Consider them for comparative context: